subject area of
- A brief survey of clinicians’ perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia Academic Article
- A case of non‐resolving hemophilia B Leyden in a 42‐year‐old male (F9 promoter + 13 A>G) Academic Article
- A pilot randomized control trial to evaluate the feasibility of an Internet-based self-management and transitional care program for youth with haemophilia Academic Article
- A preliminary application of a haemophilia value framework to emerging therapies in haemophilia Academic Article
- A study of variations in the reported haemophilia B prevalence around the world Academic Article
- A systematic review of definitions and reporting of bleeding outcome measures in haemophilia Academic Article
- A therapeutic alternative for haemophiliacs with inhibitors Academic Article
- Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV Academic Article
- An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice Conference Paper
- Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B Academic Article
- Cardiac surgery in patients with haemophilia B: a case report and review of the literature Academic Article
- Cardiovascular disease (CVD) in Canadians with haemophilia: Age-Related CVD in Haemophilia Epidemiological Research (ARCHER study) Academic Article
- Cardiovascular disease prevalence and relevance in haemophilia: a scoping review Academic Article
- Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B Academic Article
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Academic Article
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Academic Article
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Academic Article
- Comparing bleed frequency and factor concentrate use between haemophilia A and B patients Academic Article
- Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders Academic Article
- Continuous Infusion of Factor Concentrates: Review of Use in Hemophilia A and Demonstration of Safety and Efficacy in Hemophilia B Conference Paper
- Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine® ) in haemophilia B Academic Article
- Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption Academic Article
-
Core outcome set for gene therapy in haemophilia: Results of the core
HEM multistakeholder project Academic Article - Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B Academic Article
- Developing a two-sided intervention to facilitate shared decision-making in haemophilia: decision boxes for clinicians and patient decision aids for patients Academic Article
- Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment Academic Article
- Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease? Academic Article
- Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery Academic Article
- Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice Academic Article
- Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH Academic Article
- Evaluation of the sexual health in people living with hemophilia Academic Article
- Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EU Academic Article
- Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts Academic Article
- Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report Conference Paper
- HIV Infection in a Defined Population of Swedish Haemophiliacs Academic Article
- Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics Academic Article
- Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes. Academic Article
- Hemophilia gene therapy: first, do no harm Academic Article
- Hepatitis E virus infection in hemophiliacs Academic Article
- Hepatitis, Epidemiology and Liver Function in Hemophiliacs in Sweden Academic Article
- High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice Academic Article
- Immune tolerance induction for a patient with factor IX inhibitors - a case report Academic Article
- Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B Academic Article
- Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up Academic Article
- Inhibitor development in haemophilia according to concentrate Academic Article
- Inhibitor development in non-severe haemophilia across Europe Academic Article
- Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors Academic Article
-
Joint
WFH ‐ISTH session: issues in clinical trial design Academic Article - Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics Academic Article
- Limited Protective Effect of the CCR5Δ32/CCR5Δ32 Genotype on Human Immunodeficiency Virus Infection Incidence in a Cohort of Patients with Hemophilia and Selection for Genotypic X4 Virus Academic Article
- Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children Academic Article
- Low prevalence of inhibitor antibodies in the Canadian haemophilia population Academic Article
-
Methodologies for data collection in congenital haemophilia with inhibitors (
CH wI): critical assessment of the literature and lessons learned from recombinant factorVII a Academic Article - More on: are randomized clinical trials the only truth? Not always Academic Article
- Mortality and causes of death in Italian persons with haemophilia, 1990-2007 Academic Article
- Mutation Analysis in F9 Gene of 17 Families with Haemophilia B from Iran Conference Paper
- On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome Academic Article
- Orthotopic liver transplantation in a patient with combined hemophilia A and B Academic Article
- Outcomes indicators and processes in transitional care in adolescents with haemophilia: A Delphi survey of Canadian haemophilia care providers Academic Article
- Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B Academic Article
- Persistent Delivery of Factor IX in Mice: Gene Therapy for Hemophilia Using Implantable Microcapsules Academic Article
- Pharmacokinetics of recombinant and plasma-derived factor IX products in pediatric patients with severe hemophilia B Academic Article
- Prevalence of hepatitis C virus infection among patients with inherited bleeding disorders in Newfoundland. Academic Article
- Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized Academic Article
- Propagating factor IX-producing hepatocytes for haemophilia B therapy Academic Article
- Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature Academic Article
- Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors Academic Article
- Redefining Disease? The Nosologic Implications of Molecular Genetic Knowledge Academic Article
- Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy. Academic Article
- Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study Academic Article
- Survey of the Canadian hemophilia population. Academic Article
- Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis Academic Article
- Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells Academic Article
- Sustained expression of coagulation factor IX by modified cord blood-derived mesenchymal stromal cells Academic Article
- Switching patients in the age of long-acting recombinant products? Academic Article
- Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates Academic Article
- The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Academic Article
- The current state of adverse event reporting in hemophilia Academic Article
- The plasma concentration of activated protein C appears normal in patients with haemophilia Academic Article
- The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey Academic Article
- Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach Academic Article
- Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics Academic Article
- Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders Academic Article
- Validation of a composite score for clinical severity of hemophilia Academic Article
- What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia Academic Article
- [Centralized care is the basis of care programs for hemophilia patients]. Academic Article
- [Cure of hemophilia is approaching. Gene therapy is the hope]. Academic Article